Article | December 10, 2021

How DCTs Make Research More Accessible And Inclusive For Participants And Sites

Source: THREAD
GettyImages-1161156492 PS

Traditionally designed clinical trials continue to be challenged by two key issues in regard to recruitment and enrollment: difficulty enrolling enough patients and a lack of representativeness in enrolled patient populations.

In general, traditionally designed, site-based studies rely on recruiting patients from a set geography that would allow for regular visits to clinics. This approach naturally limits the pool of potential study participants, but it also locks studies into whatever level of population diversity (or lack thereof) is prevalent in that set study geography.

Using digital tools and effective DCT approaches, research stakeholders can significantly improve access to studies for both patients and sites, helping to increase the numbers of eligible participants in clinical research and the representativeness of patient populations. More diverse participant groups that better reflect the real-world population lead to better, more comprehensive data on the safety and efficacy of new therapies.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader